|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA13010030
|
1-(O-alpha-D-glucopyranosyl)-29-keto-(1,3R,31R)-dotriacontanetriol
|
1-(O-alpha-D-glucopyranosyl)-29-keto-(1,3R,31R)-dotriacontanetriol
|
|
C38H74O9
|
674.533286
|
|
LMFA08020083
|
N-docosanoyl taurine
|
N-docosanoyl-taurine
|
NAT 22:0
|
C24H49NO4S
|
447.338230
|
|
LMFA04010330
|
11-E4t-NeuroP
|
3-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010023
|
4-F4c-NeuroP
|
(S,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA05000091
|
hentriacontan-16-ol
|
hentriacontan-16-ol
|
FOH 31:0
|
C31H64O
|
452.495716
|
|
LMFA13020004
|
13-sophorosyloxydocosanoic acid
|
13-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]docosanoic acid
|
|
C34H64O13
|
680.434696
|
|
LMFA01050365
|
3S-hydroxypalmitic acid
|
3S-hydroxyhexadecanoic acid
|
FA 16:0;O
|
C16H32O3
|
272.235146
|
|
LMFA01030793
|
3-Methyl-2E-hexenoic acid
|
3-Methyl-2E-hexenoic acid
|
FA 7:1
|
C7H12O2
|
128.083730
|
|
LMFA01030793
|
3-Methyl-2E-hexenoic acid
|
3-Methyl-2E-hexenoic acid
|
FA 7:1
|
C7H12O2
|
128.083730
|
|
LMFA01060187
|
7-oxo-11Z-Tetradecenoic acid
|
7-oxo-11Z-Tetradecenoic acid
|
FA 14:2;O
|
C14H24O3
|
240.172545
|
|
LMFA01060187
|
7-oxo-11Z-Tetradecenoic acid
|
7-oxo-11Z-Tetradecenoic acid
|
FA 14:2;O
|
C14H24O3
|
240.172545
|
|
LMFA03110174
|
5-E2t-IsoP
|
(S,E)-5-hydroxy-7-((1S,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03130053
|
(9R,12S,15S)-d13-8-IsoF[8S,11S]
|
(Z)-7-((2S,3R,5S)-5-((1S,4S,E)-1,4-dihydroxynon-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA04010024
|
7-epi-4-F4t-NeuroP
|
(S,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA03130105
|
(6R,9R,12R)-d10-5-IsoF[5S,8S]
|
4-((2S,3R,5S)-5-((1R,2Z,4R,6Z)-1,4-dihydroxydodeca-2,6-dien-1-yl)-3-hydroxytetrahydrofuran-2-yl)butanoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA01170121
|
Oxoadipic acid
|
2-oxo-hexanedioic acid
|
FA 6:2;O3
|
C6H8O5
|
160.037175
|
|
LMFA01170121
|
Oxoadipic acid
|
2-oxo-hexanedioic acid
|
FA 6:2;O3
|
C6H8O5
|
160.037175
|
|
LMFA01170076
|
2-hydroxy-decanedioic acid
|
2-hydroxy-decanedioic acid
|
FA 10:1;O3
|
C10H18O5
|
218.115425
|
|
LMFA01170076
|
2-hydroxy-decanedioic acid
|
2-hydroxy-decanedioic acid
|
FA 10:1;O3
|
C10H18O5
|
218.115425
|
|
LMFA01050384
|
2,3-dihydroxy-valeric acid
|
2,3-dihydroxy-pentanoic acid
|
FA 5:0;O2
|
C5H10O4
|
134.057910
|
|
LMFA01050417
|
alpha-hydroxy-isobutyric acid
|
2-hydroxy-2-methyl-propanoic acid
|
FA 4:0;O
|
C4H8O3
|
104.047345
|
|
LMFA01050417
|
alpha-hydroxy-isobutyric acid
|
2-hydroxy-2-methyl-propanoic acid
|
FA 4:0;O
|
C4H8O3
|
104.047345
|
|
LMFA01050397
|
4-deoxy-erythronic acid
|
2,3-dihydroxy-butanoic acid
|
FA 4:0;O2
|
C4H8O4
|
120.042260
|
|
LMFA07010193
|
2E,6Z-Octadienyl acetate
|
2E,6Z-Octadienyl acetate
|
SFE 10:2
|
C10H16O2
|
168.115030
|
|
LMFA07010193
|
2E,6Z-Octadienyl acetate
|
2E,6Z-Octadienyl acetate
|
SFE 10:2
|
C10H16O2
|
168.115030
|
|
LMFA07010242
|
SFE 12:1(3Z)/2:0
|
3Z-Dodecenyl acetate
|
SFE 14:1
|
C14H26O2
|
226.193280
|
|
LMFA07010242
|
SFE 12:1(3Z)/2:0
|
3Z-Dodecenyl acetate
|
SFE 14:1
|
C14H26O2
|
226.193280
|
|
LMFA01020392
|
3-Methyl-2E-heptenoic acid
|
3-Methyl-2E-heptenoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA01020392
|
3-Methyl-2E-heptenoic acid
|
3-Methyl-2E-heptenoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA04020116
|
(10R,14R,17R)-d11-13-NeuroF[13R,16R]
|
(R,4Z,7Z,11E)-10-hydroxy-12-((2R,3R,5R)-3-hydroxy-5-((R,Z)-1-hydroxyhex-3-en-1-yl)tetrahydrofuran-2-yl)dodeca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA01020314
|
Mycocerosic acid (C30)
|
2R,4R,6R,8R-tetramethyl-hexacosanoic acid
|
FA 30:0
|
C30H60O2
|
452.459331
|
|
LMFA04020053
|
(13R,16R,20S)-d18-14-NeuroF[14R,17R]
|
(R,4Z,7Z,10Z)-13-hydroxy-13-((2R,4R,5R)-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020126
|
(10R,14S,17S)-d11-13-NeuroF[13S,16R]
|
(R,4Z,7Z,11E)-10-hydroxy-12-((2S,3S,5R)-3-hydroxy-5-((S,Z)-1-hydroxyhex-3-en-1-yl)tetrahydrofuran-2-yl)dodeca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA01020325
|
Hydroxyphthioceranic acid (C39)
|
2S,4S,6S,8S,10R,12R,14R-heptamethyl-15-hydroxy-dotriacontanoic acid
|
FA 39:0;O
|
C39H78O3
|
594.595096
|
|
LMFA01020325
|
Hydroxyphthioceranic acid (C39)
|
2S,4S,6S,8S,10R,12R,14R-heptamethyl-15-hydroxy-dotriacontanoic acid
|
FA 39:0;O
|
C39H78O3
|
594.595096
|
|
LMFA04020210
|
(4R,7R,11R)-d9-5-NeuroF[5R,8S]
|
(R)-4-hydroxy-4-((2R,4R,5S)-4-hydroxy-5-((R,1E,5Z,8Z,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)tetrahydrofuran-2-yl)butanoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA06000158
|
7E,9Z-Dodecadienal
|
7E,9Z-Dodecadienal
|
FAL 12:2
|
C12H20O
|
180.151415
|
|
LMFA06000167
|
5Z,7Z-Dodecadienal
|
5Z,7Z-Dodecadienal
|
FAL 12:2
|
C12H20O
|
180.151415
|
|
LMFA06000218
|
10Z,12E-Hexadecadienal
|
10Z,12E-Hexadecadienal
|
FAL 16:2
|
C16H28O
|
236.214015
|
|
LMFA01020336
|
Mycolipenic acid (C25)
|
2,4S,6S-trimethyl-2E-docosenoic acid
|
FA 25:1
|
C25H48O2
|
380.365431
|
|
LMFA01020336
|
Mycolipenic acid (C25)
|
2,4S,6S-trimethyl-2E-docosenoic acid
|
FA 25:1
|
C25H48O2
|
380.365431
|
|
LMFA05000688
|
Panaquinquecol 7
|
8-(3-heptyloxiran-2-yl)-1-hydroxyocta-4,6-diyn-3-one
|
FOH 17:6;O2
|
C17H24O3
|
276.172545
|
|
LMFA08020084
|
N-arachidonoyl dopamine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-dopamine
|
NA 28:8;O2
|
C28H41NO3
|
439.308644
|
|
LMFA08020084
|
N-arachidonoyl dopamine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-dopamine
|
NA 28:8;O2
|
C28H41NO3
|
439.308644
|
|
LMFA08020084
|
N-arachidonoyl dopamine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-dopamine
|
NA 28:8;O2
|
C28H41NO3
|
439.308644
|
|
LMFA08020084
|
N-arachidonoyl dopamine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-dopamine
|
NA 28:8;O2
|
C28H41NO3
|
439.308644
|
|
LMFA03110179
|
ent-5-epi-5-E2c-IsoP
|
(S,E)-5-hydroxy-7-((1S,2R,3S)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA01020056
|
5-methyl-undecanoic acid
|
5-methyl-undecanoic acid
|
FA 12:0
|
C12H24O2
|
200.177630
|
|
LMFA02000057
|
2R-hydroxy-linoleic acid
|
2R-hydroxy-9Z,12Z-octadecadienoic acid
|
FA 18:2;O
|
C18H32O3
|
296.235146
|
|
LMFA02000057
|
2R-hydroxy-linoleic acid
|
2R-hydroxy-9Z,12Z-octadecadienoic acid
|
FA 18:2;O
|
C18H32O3
|
296.235146
|